Other languages Biogen Inc. Xetra

Equities

IDP

US09062X1037

Real-time Estimate Tradegate Other stock markets 05:11:03 2024-05-22 EDT			5-day change	1st Jan Change
209.5 ^EUR	+0.19%		-2.47%	-10.78%

05-16	Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	MT
05-16	Sector Update: Health Care Stocks Ease Thursday Afternoon	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	05-16
Sector Update: Health Care Stocks Ease Thursday Afternoon	05-16
US Equity Indexes Trade Mixed as Investors Weigh Macro Data; Dow Touches Record High	05-16
Sector Update: Health Care	05-16
Dow Touches 40,000 Mark for First Time as Macroeconomic Data Signals Economic Weakness	05-16
Ionis Pharmaceuticals Says Potential Angelman Syndrome Therapy Improves Symptoms in Phase 1/2a Study	05-16
Sector Update: Health Care Stocks Steady Premarket Thursday	05-16
Biogen, Ionis to Cease BIIB105 ALS Investigational Drug Development Following Phase 1/2 Trial Results	05-16
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	05-16
Valores destacados al cierre del mercado norteamericano	05-16
Sector Update: Health Care Stocks Advance Late Wednesday Afternoon	05-15
Sector Update: Health Care Stocks Advance in Afternoon Trading	05-15
Sector Update: Health Care	05-15
Equity Markets Rise Intraday as Consumer Inflation Cools	05-15
S&P 500, Nasdaq Composite Touch Record Highs After Consumer Price Index Eases	05-15
Easing Inflation Spurs S&P 500, Nasdaq Composite to Record Highs	05-15
Biogen Partner Eisai Submits FDA Biologics Application for Early Alzheimer's Self-Injection Drug	05-15
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA	05-15
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (Lecanemab-Irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status	05-14
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA	05-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biogen Inc. Xetra

Equities

IDP

US09062X1037

Other languages

Filters